Elevation Wealth Partners’s Boston Scientific BSX Stock Holding History

Elevation Wealth Partners’s Portfolio BSX Stock Details BSX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$34.9K	Buy	799 +566	+243%	+$26.2K	0.01%	490
2026 Q2	$9.95K	Sell	233 -253	-52%	-$13.7K	﹤0.01%	811
2026 Q1	$30.5K	Buy	486 +341	+235%	+$27.3K	0.01%	305
2025 Q4	$13.8K	Buy	145 +28	+24%	+$2.75K	﹤0.01%	438
2025 Q3	$11.4K	Buy	+117	New	+$12.1K	﹤0.01%	379
2024 Q3	–	Sell	-67	Closed	-$5.16K	–	489
2024 Q2	$5.16K	Buy	+67	New	+$4.9K	﹤0.01%	382

Other funds holding BSX

Gradient Investments Arden Hills, Minnesota $7B AUM 14.85% 1-Year Est. Return

MSV

MN Services Vermogensbeheer The Hague, Netherlands $13.4B AUM 37.34% 1-Year Est. Return

NPPM

North Point Portfolio Managers Orange Village, Ohio $595M AUM 14.89% 1-Year Est. Return

FFA

Farther Finance Advisors San Francisco, California $14.2B AUM 18.33% 1-Year Est. Return

GAMMA Investing Foster City, California $2.96B AUM 34.38% 1-Year Est. Return

NRS

Neville Rodie & Shaw New York $1.48B AUM 34.49% 1-Year Est. Return

QPBE

Quintet Private Bank (Europe) Luxembourg $2.28B AUM 23.89% 1-Year Est. Return

Persium Advisors Atlanta, Georgia $191M AUM 23.01% 1-Year Est. Return

IRC

Investors Research Corp Atlanta, Georgia $569M AUM 15.41% 1-Year Est. Return

EFG

Everhart Financial Group Dublin, Ohio $1.62B AUM 25.73% 1-Year Est. Return

Elevation Wealth Partners's BSX Position: Q3 2026 in Review

Elevation Wealth Partners increased its Boston Scientific (BSX) stake by 243% in Q3 2026, buying an estimated $26.2K and bringing the position to 799 shares worth $34.9K. The position accounts for 0.01% of the portfolio, ranked #490.

Elevation Wealth Partners first reported a position in BSX in Q2 2024 and has held it in 6 quarters since. 43 funds tracked by Wall St. Rank hold BSX as of Q3 2026.

Elevation Wealth Partners held 799 shares of Boston Scientific worth $34.9K as of Q3 2026.
Elevation Wealth Partners bought 566 Boston Scientific shares in Q3 2026, an estimated $26.2K.
Boston Scientific made up 0.01% of Elevation Wealth Partners's portfolio in Q3 2026, its #490 holding.
Elevation Wealth Partners first reported a position in Boston Scientific in Q2 2024 and has held it in 6 quarters since.
43 funds tracked by Wall St. Rank held Boston Scientific as of Q3 2026.

Based on Elevation Wealth Partners's 13F filing for Q3 2026, filed 7 Oct 2026.